Literature DB >> 22018910

Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.

Sydney E Seidel1, Barbara C Tilley, Peng Huang, Yuko Y Palesch, Kenneth J Bergmann, Christopher G Goetz, Christopher J Swearingen.   

Abstract

OBJECTIVE: To evaluate the subject-investigator agreement on the Unified Parkinson's Disease Rating Scale (UPDRS) subsections I and II.
METHODS: Subject-investigator agreement was estimated at baseline and endpoint by Kappa statistics for individual items and concordance correlations for subscale totals using data from two NIH Exploratory Trials in Parkinson's Disease studies.
RESULTS: All but two questions had moderate subject-investigator agreement at baseline and endpoint. Participants consistently rated their disease activity worse that investigators.
CONCLUSION: UPDRS self-administration produces similar results to investigator-administration. Although slightly elevated, UPDRS self-administration can be accommodated in a clinical trial setting.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018910      PMCID: PMC3288816          DOI: 10.1016/j.parkreldis.2011.10.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  22 in total

1.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

2.  Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings.

Authors:  Cynthia McRae; Gretchen Diem; Alexander Vo; Christopher O'Brien; Lauren Seeberger
Journal:  Parkinsonism Relat Disord       Date:  2002-01       Impact factor: 4.891

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.

Authors:  M Richards; K Marder; L Cote; R Mayeux
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

5.  Correlation of patient and caregiver ratings of cancer pain.

Authors:  S A Grossman; V R Sheidler; K Swedeen; J Mucenski; S Piantadosi
Journal:  J Pain Symptom Manage       Date:  1991-02       Impact factor: 3.612

6.  Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?

Authors:  Pablo Martínez-Martín; Julian Benito-León; Fernando Alonso; M José Catalán; Margarita Pondal; Aurelio Tobías; Ivana Zamarbide
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

7.  Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program.

Authors:  Christopher G Goetz; Peter A LeWitt; Meredith Weidenman
Journal:  Mov Disord       Date:  2003-12       Impact factor: 10.338

8.  Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.

Authors:  Claudia Ramaker; Johan Marinus; Anne Margarethe Stiggelbout; Bob Johannes Van Hilten
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

9.  Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

Authors:  P Martínez-Martín; A Gil-Nagel; L M Gracia; J B Gómez; J Martínez-Sarriés; F Bermejo
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

View more
  2 in total

Review 1.  Telemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A Neurosurgical Perspective.

Authors:  Rachel Blue; Andrew I Yang; Cecilia Zhou; Emma De Ravin; Clare W Teng; Gabriel R Arguelles; Vincent Huang; Connor Wathen; Stephen P Miranda; Paul Marcotte; Neil R Malhotra; William C Welch; John Y K Lee
Journal:  World Neurosurg       Date:  2020-05-16       Impact factor: 2.104

Review 2.  Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson's Disease: A Regulatory Perspective.

Authors:  Leonard Sacks; Elizabeth Kunkoski
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.